K Griffin
3 Papers
K Griffin is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Adherence to very-low-fat diet by a group of cardiac rehabilitation patients in the rural southeastern United States.
TL;DR: It is concluded that motivated patients with coronary artery disease can follow a very-low-fat, near vegetarian diet but experience difficulty without a structured program.
66
Improved Glycemia with Hybrid Closed-Loop (HCL) Versus Continuous Subcutaneous Insulin Infusion (CSII) Therapy: Results from a Randomized Controlled Trial.
Satish K. Garg,George Grunberger,Ruth S. Weinstock,Margaret L. Lawson,Irl B. Hirsch,Linda A. DiMeglio,Rodica Pop-Busui,Athena Philis-Tsimikas,Mark Kipnes,David R Lilenquist,Ronald L. Brazg,Yogish C. Kudva,Bruce A. Buckingham,Janet B. McGill,Anders E. Carlson,Amy Criego,Mark P. Christiansen,Kevin B Kaiserman,K Griffin,Gregory P. Forlenza,Bruce W. Bode,Robert H. Slover,Ashleigh Keiter,Chenxiao Ling,B.A. Marinos,Toni L. Cordero,John J. Shin,Scott W. Lee,Andrew S. Rhinehart,Robert A. Vigersky +29 more
TL;DR: In this article , the authors evaluated the safety and effectiveness of MiniMed 670G hybrid closed loop in comparison with continuous subcutaneous insulin infusion (CSII) therapy for six months, in persons with Type 1 diabetes (T1D).
32
Type 1 Diabetes Prevention: a systematic review of studies testing disease-modifying therapies and features linked to treatment response
Jamie Felton,K Griffin,Richard A. Oram,Cate Speake,S. Alice Long,Suna Onengut-Gumuscu,Stephen S. Rich,G. Monaco,Carmella Evans-Molina,Linda A. DiMeglio,Heba M. Ismail,Andrea K. Steck,Dana Dabelea,Rebecca A. Johnson,Marzhan Urazbayeva,Stephen E. Gitelman,Joan Wentworth,Maria J. Redondo,Emily K. Sims,O. B. O. T. C. Consortium +19 more
TL;DR: A systematic review of randomized-controlled trials from the past 25 years testing disease-modifying therapies in Type 1 diabetes and identifying features linked to treatment response, analyzing bias using a Cochrane-risk-of-bias instrument was performed in this paper .